{"id":1538961,"date":"2019-05-31T11:37:00","date_gmt":"2019-05-31T09:37:00","guid":{"rendered":"http:\/\/nhub.news\/?p=1538961"},"modified":"2019-06-01T05:42:18","modified_gmt":"2019-06-01T03:42:18","slug":"concerns-over-exaggerated-health-claims-prompts-fda-hearing-on-effects-of-cbd-products","status":"publish","type":"post","link":"http:\/\/nhub.news\/de\/2019\/05\/concerns-over-exaggerated-health-claims-prompts-fda-hearing-on-effects-of-cbd-products\/","title":{"rendered":"Concerns over exaggerated health claims prompts FDA hearing on effects of CBD products"},"content":{"rendered":"

On Friday, the US Food and Drug Administration is holding its first hearing to assess the safety and efficacy of these CBD products.<\/b>
\n„Its critical that we address these unanswered questions about CBD and other cannabis and cannabis-derived products to help inform the FDAs regulatory oversight of these products,“ he said. „Especially as the agency considers whether it could be appropriate to exercise its authority to allow the use of CBD in dietary supplements and other foods.“<\/p>\n